For Institutions
GMP Products & Services
Research-Grade Products & Services
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
Menu
For Institutions
GMP Products & Services
Research-Grade Products & Services
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
For Institutions
GMP Products & Services
Research-Grade Products & Services
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
For Institutions
GMP Products & Services
Research-Grade Products & Services
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
Icon-twitter-x
Facebook-f
News
All
Press
Media
Events
Other
CEO Koji Tanabe presents at the 2022 International Summit Forum on Cell Therapy and Regenerative Medicine in Taiwan
•
October 28, 2022
•
Events
GMP cell CDMO I Peace, Inc. in collaboration with universities successfully converted human dermal fibroblasts into oligodendrocyte by direct reprogramming
•
September 20, 2022
•
Press
I Peace in the News – the Nikkei on, 2022
•
August 3, 2022
•
Media
A new automated iPSC high-throughput induction system to induce thousands of iPSC lines simultaneously
To be presented at ISSCR 2022 Annual Meeting
•
June 15, 2022
•
Press
I Peace accelerates allogeneic iPSC-derived cell therapies with a high throughput method to identify a large number of donors with specific HLA haplotypes
•
May 12, 2022
•
Press
I Peace triples GMP cell manufacturing by expanding CDMO facility
•
March 14, 2022
•
Press
I Peace’s Cell Manufacturing Facility “Peace Engine-Kyoto”now registered as U.S. FDA Drug Establishment
•
January 26, 2022
•
Press
[Summary of Research]Anti-cancer therapeutic potential of tumoricidal T cells regenerated from tumor-infiltrating lymphocyte-derived iPS cells
•
October 19, 2021
•
Other
Koji Tanabe, CEO of I Peace, Inc.
honored by World Biz Magazine with
the “ Top 100 Innovation CEO” Award
•
September 22, 2021
•
Press
Stem Cells for Everyone: I Peace expands its clinical-grade iPSC banking service leveraging mass manufacturing capability
•
September 7, 2021
•
Press
Reach out to us to learn more
Contact Us